Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Czechia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20163
20171
20182
20202
20215
20221
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Active, not recruiting3
Unknown status3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
General University Hospital, Prague3
Inventiva Pharma2
Novo Nordisk A/S2
University Hospital Ostrava2
89bio, Inc.1
Astellas Pharma Inc1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Charles University, Czech Republic1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease22
Fatty Liver7
Liver Cirrhosis6
Fibrosis4
Liver Diseases4
Obesity3
Digestive System Diseases2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Hepatitis C1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.